News

Case study of patient save also presented at Heart Rhythm 2023

Self-administration of etripamil in patients experiencing AFib-RVR episodes resulted in a substantial reduction in ventricular rate which was sustained over 60 minutes

KYOTO, Japan, May 23, 2023 /-- OMRON Healthcare Co., Ltd. based in Muko City, Kyoto Prefecture, Japan, is proud to announce the celebration of its 50th anniversary in blood pressure monitor production this year. Since the...

St. Louis, May 23, 2023 – Stereotaxis, the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the first treatment of patients with a newly launched Genesis Robotic Magnetic Navigation (RMN)...

Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug Administration Approval and Commercialization

Clinical studies presented at Heart Rhythm 2023 build on the totality of clinical evidence that continue to highlight the value of iRhythm’s Zio products and services across a wide range of patient populations

High BMI patients who lost 3% or more of their body weight prior to ablation saw greater freedom from AF post-ablation

The BIO-LIBRA trial successfully enrolled 48% women and 30% non-white patients with non-ischemic cardiomyopathy treated with implanted defibrillator devices

Philips presented an abstract highlighting recent research demonstrating how AI may be used to help predict life-threatening ventricular arrhythmias.

Results show model correctly identified ventricular arrhythmias in 88% of patients with sustained ventricular tachycardia